By Priscila Mayumi Kashiwabara
29 de May de 2020
Biologics and biosimilars in Brazil – the strategic questions
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Back
Share:
Last by Priscila Mayumi Kashiwabara
29 de May de 2026
Kasznar Leonardos has been ranked by IAM Patent 1000
It is with great honor that we announce that we have once again been ranked in the IAM Patent 1000. In the … Kasznar Leonardos has been ranked by IAM Patent 1000
17 de June de 2025
Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation
On June 11th, 2025, the Brazilian Senate approved Legislative Decree No. 466/2022, ratifying Brazil’s accession to the Budapest Treaty on the International … Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation
29 de May de 2025
Kasznar Leonardos was ranked on IAM Patent 1000
We are proud to announce that we have been ranked in the IAM Patent 1000 2025, a specialized ranking in the field … Kasznar Leonardos was ranked on IAM Patent 1000